• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

基于聚焦抗抑郁药临床评估的新发布指南对抗抑郁药未来发展的期望

[Expectation for future development of antidepressant based on the newly published guideline focusing on clinical evaluation of antidepressants].

作者信息

Uyama Yoshiaki

机构信息

Pharmaceuticals and Medical Devices Agency, Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki, Chiyodaku, Tokyo 100-0013, Japan.

出版信息

Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Aug;31(4):177-80.

PMID:21941852
Abstract

The guideline to evaluate clinical response to antidepressants was newly published on November 16, 2010, in Japan, and provides useful suggestions in the development of new antidepressants. In this paper, the background of the establishment of the guideline and a perspective for the future development of antidepressants are described from a personal viewpoint.

摘要

评估抗抑郁药临床反应的指南于2010年11月16日在日本新发布，为新型抗抑郁药的研发提供了有益建议。本文从个人角度阐述了该指南制定的背景以及抗抑郁药未来发展的前景。

相似文献

1
[Expectation for future development of antidepressant based on the newly published guideline focusing on clinical evaluation of antidepressants].基于聚焦抗抑郁药临床评估的新发布指南对抗抑郁药未来发展的期望
Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Aug;31(4):177-80.
2
[Development of a Guideline on Clinical investigation of Medicinal Product in the Treatment of Depression in Japan].
Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Aug;31(4):169-76.
3
[Current and future views from pharmaceutical industry perspectives on development of antidepressants].[制药行业对抗抑郁药研发的当前及未来观点]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Aug;31(4):181-6.
4
[The revision of Guidelines for Clinical Evaluation Methods of Anti-Cancer Drugs in Japan].[日本抗癌药物临床评价方法指南的修订]
Gan To Kagaku Ryoho. 2006 Jul;33(7):1015-9.
5
Efficacy of antidepressants and USPSTF guidelines for depression screening.抗抑郁药的疗效及美国预防医学工作组抑郁症筛查指南
Ann Intern Med. 2010 Jun 1;152(11):753; author reply 753-4. doi: 10.7326/0003-4819-152-11-201006010-00016.
6
The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications.指南一致的抑郁症治疗与患者口服糖尿病药物依从性之间的关系。
Res Social Adm Pharm. 2005 Sep;1(3):378-88. doi: 10.1016/j.sapharm.2005.06.001.
7
Enhancing the technology of clinical trials and the trials model to evaluate newly developed, targeted antidepressants.加强临床试验技术和试验模式，以评估新开发的靶向抗抑郁药。
Neuropsychopharmacology. 2002 Sep;27(3):319-28. doi: 10.1016/S0893-133X(02)00329-9.
8
Study designs and outcomes in antidepressant clinical trials.抗抑郁药物临床试验的研究设计与结果
Essent Psychopharmacol. 2005;6(4):221-6.
9
Combined antidepressants: clinical experience.联合使用抗抑郁药：临床经验
Acta Psychiatr Scand Suppl. 2005(428):25-31, 36. doi: 10.1111/j.1600-0447.2005.00677.x.
10
Multidimensional assessment of acute and long-term effects in antidepressant drug trials.抗抑郁药物试验中急性和长期效应的多维评估。
Pharmacopsychiatry. 1994 Jul;27 Suppl 1:18-20. doi: 10.1055/s-2007-1014320.